Lawrence, J A <br/><br/>
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 2001 
 - 2754-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.10.2754  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alitretinoin<br/>Antigens, Nuclear<br/>Antineoplastic Agents--adverse effects<br/>Area Under Curve<br/>Biomarkers<br/>Breast Neoplasms--drug therapy<br/>Cholesterol--blood<br/>Chromatography, High Pressure Liquid<br/>Female<br/>Humans<br/>Ki-67 Antigen<br/>Middle Aged<br/>Nuclear Proteins--isolation & purification<br/>Tamoxifen--therapeutic use<br/>Tretinoin--adverse effects